EW vs STRO
Edwards Lifesciences Corp (EW) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EW and STRO stock pages for the full models.
Not investment advice.